CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...